SYDNEY: Australian researchers are fast-tracking large-scale human testing to see if a vaccine used for decades to prevent tuberculosis can protect health workers from COVID-19, they announced on Friday (Mar 27).
The trial of the BCG vaccine will be conducted with 4,000 health workers in hospitals around Australia to determine if it can reduce COVID-19 symptoms, the researchers at the Murdoch Children's Research Institute in Melbourne said.